Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2007

View Archived Issues

BioGeneriX and Neose extend GlycoPEG-GCSF collaboration

NovaDel raises funds to advance oral spray drug candidates

Thalidomide to be evaluated for the treatment of MIA syndrome in dialysis patients / News in Context

Grazax launched in U.K., Denmark and Norway

FDA approval for generic Atenolol Tablets

Shandong Luye acquires cancer drug CMNa

Exelixis and Genentech sign agreement for MEK inhibitor XL-518

4SC and XL TechGroup form new company to develop biofilm inhibitors

Grifols receives FDA approval for new generation of IVIG

Zydus launches Simvastatin Tablets

Perrigo receives FDA approval for Ciclopirox Topical Suspension

REG1 anticoagulant system safe in humans

VGX-1027 active against diabetes in preclinical models

PRO-132365 investigated in breast cancer trial

E75 vaccine safe and active in high-risk breast cancer

Novel monoamine reuptake inhibitors emerge from NeuroSearch R&D

Novel antibacterial agents patented

New CCR-5 receptor modulators prepared and tested at Kemia

Higher recovery rate after stroke for DP-b99-treated patients

Transdur-Bupivacaine begins phase II for postherpetic neuralgia

Phase II program under way for TD-1792 in Gram-positive cSSSI

SPA agreement for pivotal phase III study of picoplatin in SCLC

U.K. clearance for clinical study of Reolysin with docetaxel in advanced cancers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...